🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 852387208 (prev. G6674U108 )
- Market Cap
- Large Cap
- IPO
- 10/1/2015 · $22.00/share
Business: NovoCure Ltd. is a commercial-stage oncology company developing a novel, proprietary therapy called Tumor Treating Fields, or TTFields, for the treatment of solid tumor cancers. Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Germany, Switzerland, and Japan and a research center in Haifa, Israel.
Company Contact
- CEO
- Asaf Danziger
- CFO
- Ashley Cordova
- Headquarters
- 195 Commerce Way, Portsmouth, NH 03801
- Phone
- 212-767-7530
- Investor Relations
- Gabrielle Fernandes · 603-206-7047 · gfernandes@novocure.com